A carregar...
In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis
BACKGROUND: Indications for use of tolvaptan in SIADH-associated hyponatraemia remain controversial. We audited our local guidelines for Tolvaptan use in this situation to review treatment implications including drug safety, hospital admission episode analysis (episodes of liver toxicity, CNS myelin...
Na minha lista:
| Publicado no: | BMC Endocr Disord |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5674865/ https://ncbi.nlm.nih.gov/pubmed/29110656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-017-0214-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|